GlassScriptPhysician profile
Glenn A Henning
NPI 1699871673
$2,943.58
in general payments reported to CMS, 2019-2025
10 companies · $1,049 in 2025
The $1,049 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $22.43 · 2022: $1,229 · 2023: $371 · 2024: $273 · 2025: $1,049.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $855 · Travel and Lodging: $693 · Long Term Medical Supply Or Device Loan: $145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $854.76 |
| Travel and Lodging | $692.50 |
| Long Term Medical Supply Or Device Loan | $145.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Crossroads Orthopedics, LLC | $1,301.46 | 2022-2023 | |
| Treace Medical Concepts, INC. | $1,071.66 | 2024-2025 | |
| Integra Lifesciences Corporation | $183.04 | 2023 | Acell, Tenoglide |
| Organogenesis INC. | $108.62 | 2021-2024 | Puraply |
| Zimmer Biomet Holdings, INC. | $97.51 | 2023-2024 | Ncb, Affixus, Znn |
| W. L. Gore & Associates, INC. | $65.99 | 2025 | Gore Viabahn Endoprosthesis |
| Bone Support INC. | $56.98 | 2024 | Cerament G, Ceramentbone Void Filler |
| Stryker Corporation | $29.42 | 2023-2024 | Charlotte, Ortholoc 2 Lapifuse |
| Solventum Corporation | $15.64 | 2025 | V.A.C.Instill, Prevena |
| Vericel Corporation | $13.26 | 2023 | Maci |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Glenn Henning listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.